Latest Trending Discover Timelines Categories
←All explainers

Technology explainer

How the First Hours of Targeted Therapy Can Reveal a Later Cancer Response

An evergreen guide to rapid pharmacodynamic profiling, single-cell signaling measurements and the validation needed before an early-response biomarker can guide treatment.

Targeted cancer drugs can alter intracellular signaling within minutes or hours. Measuring blood before and shortly after a dose can therefore reveal whether the intended pathway changed and how immune-cell populations reacted.

Single-cell methods preserve differences between cell types that would disappear in an average bulk measurement. Mass cytometry can quantify dozens of surface and signaling markers across millions of cells.

Researchers can compare these early profiles with molecular or clinical outcomes measured months later. A reproducible association may become a response biomarker, but only after the assay, processing time and prediction rule are standardized.

Clinical use requires prospective validation on independent patients and a predefined action. The key question is not only whether the test predicts response, but whether acting on it improves treatment decisions and outcomes.

First appeared in

Single-Cell Blood Profiles Predicted Leukemia Drug Response From Changes Seen Within Three Hours

A new version of NewTqnia is ready.